Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
E7386
i
Other names:
E7386, E 7386, E-7386
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Eisai, PRISM Pharma
Drug class:
CBP inhibitor, β-catenin inhibitor, Wnt signalling pathway inhibitor
Related drugs:
‹
eribulin mesylate (47)
PRI724 (5)
CCS1477 (4)
FT-6876 (1)
AU-18069 (0)
AUR-107 (0)
EP31670 (0)
NEO1132 (0)
BC2059 (2)
FOG-001 (0)
KY1022 (0)
MCI-030 (0)
MRX34 (0)
WNT974 (2)
CGX1321 (1)
NCB-0846 (1)
XAV-939 (1)
OMP-18R5 (1)
Circ0003039 (0)
OMP-54F28 (0)
eribulin mesylate (47)
PRI724 (5)
CCS1477 (4)
FT-6876 (1)
AU-18069 (0)
AUR-107 (0)
EP31670 (0)
NEO1132 (0)
BC2059 (2)
FOG-001 (0)
KY1022 (0)
MCI-030 (0)
MRX34 (0)
WNT974 (2)
CGX1321 (1)
NCB-0846 (1)
XAV-939 (1)
OMP-18R5 (1)
Circ0003039 (0)
OMP-54F28 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.